Company intelligence / Profile preview

Anke Biotech

Hefei, Anhui, China
Ownership
Private
Employees
~2800
Development stage
Other
01

Overview

Anke Biotech is a prominent Chinese biopharmaceutical company focused on the research, development, and commercialization of recombinant DNA products and diagnostic reagents. The company is a market leader in China for its flagship products, Ansomone (recombinant human growth hormone) and Anterferon (recombinant human interferon alpha-2b), which address endocrine disorders and viral infections. Anke Biotech has strategically expanded its portfolio into oncology and precision medicine, developing a pipeline of monoclonal antibodies and advanced cell therapies like CAR-T. Listed on the Shenzhen Stock Exchange since 2009, the company operates extensive GMP-certified manufacturing facilities in Hefei. Its business model integrates traditional biopharmaceuticals with modern genomic diagnostics and forensic services.

Therapeutic areas
Infectious DiseasesOncologyEndocrinology
Modalities
HormoneCytokineMonoclonal antibodyCAR-T cell therapyRecombinant protein
Industry
Biotech

Beyond the preview

Go deeper on Anke Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anke Biotech.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call